714
Views
16
CrossRef citations to date
0
Altmetric
Report

Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase

, , , , &
Pages 3492-3503 | Published online: 16 Aug 2012
 

Abstract

Ectopic viral integration site 1 (EVI1), a transcription factor frequently overexpressed in myeloid neoplasias, has been implicated in the generation of malignancy-associated centrosomal aberrations and chromosomal instability. Here, we sought to investigate the underlying cause of centrosome amplification in EVI1-overexpressing cells. We found that overexpression of EVI1-HA in U2OS cells induced supernumerary centrosomes, which were consistently associated with enlarged nuclei or binuclear cells. Live cell imaging experiments identified cytokinesis failure as the underlying cause of this phenotype. In accordance with previous reports, EVI1 overexpression induced a partial cell cycle arrest in G0/1 phase, accompanied by elevated cyclin D1 and p21 levels, reduced Cdk2 activity and activation of the p53 pathway. Supernumerary centrosomes predominantly occurred in resting cells, as identified by low levels of the proliferation marker Ki-67, leading to the conclusion that they result from tetraploidization after cytokinesis failure and are confined to G0/1-arrested tetraploid cells. Depletion of p53 using siRNA revealed that further polyploidization of these cells was inhibited by the p53-dependent tetraploidy checkpoint.

This article is referred to by:
New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

We thank Manuel Grez for the EVI1 plasmid, Erich A. Nigg for the Cep170 antibody, Luigi Naldini for providing lentiviral packaging plasmids and the transfer vector pCCL.SIN.cPPT.SFFV.IRES.eGFP.wPRE and Sigrid Heil for excellent technical assistance. Support by the DKFZ Light Microscopy Facility and the Carl Zeiss Application Center, Heidelberg, is gratefully acknowledged. This work was supported by the Deutsche Forschungsgemeinschaft, grant SFB873, and by the Deutsche Krebshilfe, grants 108560, 10–1860-GI I and 107217.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.